Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control.

about

Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control.

Item

http://www.wikidata.org/entity/Q49459405

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Elucidating the impact of the ...... and using a composite control.

@en

Elucidating the impact of the ...... and using a composite control.

@nl

type

Item

label

Elucidating the impact of the ...... and using a composite control.

@en

Elucidating the impact of the ...... and using a composite control.

@nl

prefLabel

Elucidating the impact of the ...... and using a composite control.

@en

Elucidating the impact of the ...... and using a composite control.

@nl

P1476

Elucidating the impact of the ...... and using a composite control.

@en

P2093

Albert Jan van Hoek

http://www.w3.org/2001/XMLSchema#string

Elizabeth Miller

http://www.w3.org/2001/XMLSchema#string

Julia Stowe

http://www.w3.org/2001/XMLSchema#string

Nick Andrews

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes

Estimating the population-level impact of vaccines using synthetic controls.

Challenges to estimating vaccine impact using hospitalization data.

Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England.

P2888

s12916-018-1004-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12916-018-1004-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dominic Thorrington

P577

2018-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29415741

http://www.w3.org/2001/XMLSchema#string

P932

5804014

http://www.w3.org/2001/XMLSchema#string